Menopause and Emotional Wellbeing: Looking Beyond Physical Symptoms

Conversations around menopause often focus on its most recognizable physical changes. But this life stage can also influence how women feel, sleep and perceive themselves.

Changes in mood, sleep quality and confidence can occur alongside the menopausal transition, and these experiences rarely exist in isolation. They can overlap and influence one another, making emotional wellbeing an increasingly important part of the wider conversation around healthy ageing and women’s health.

A broader understanding of wellbeing during menopause

Emotional wellbeing is not defined by mood alone.

Sleep difficulties may affect how someone feels the following day. Changes in emotional balance may influence confidence and everyday resilience. At the same time, the way women perceive and experience this stage of life can also contribute to their overall sense of wellbeing.

This interconnected picture is encouraging researchers to consider menopause from a broader perspective rather than examining individual symptoms separately.

For the nutraceutical industry, that shift is particularly relevant. Consumers are increasingly looking for solutions that fit into a more complete approach to wellbeing rather than addressing one isolated concern.

Why saffron is attracting scientific interest

Saffron has become an increasingly studied botanical ingredient in areas related to emotional wellbeing and sleep.

Research into standardized saffron extracts has explored several pathways associated with these areas, contributing to growing scientific interest in its potential role within formulations focused on mental and emotional wellbeing.

Affron®, Pharmactive’s standardized saffron extract, has been investigated across several clinical studies involving mood, sleep and different population groups.

Recent research has extended that scientific programme specifically into women experiencing low mood and poor sleep during and after the menopausal transition.

New research with Affron®

A randomized, double-blind, placebo-controlled clinical trial published in Frontiers in Nutrition evaluated Affron® in women aged 50 to 70 years experiencing low mood and poor sleep.

Over 12 weeks, researchers assessed several dimensions of wellbeing rather than focusing on one outcome alone.

The study reported improvements in measures related to mood, sleep-related wellbeing and self-esteem, adding a new perspective to research into emotional health during this stage of life.

This is particularly interesting because it reflects the way women may actually experience menopause: as a combination of interconnected changes rather than a collection of completely separate symptoms.

What this means for women’s health innovation

The research reflects a broader direction within the women’s health category.

Menopause is increasingly being considered within the context of healthy ageing, emotional wellbeing, sleep and quality of life, opening new opportunities for product developers to think beyond traditional menopause positioning.

For supplement brands and formulators, this creates potential across areas such as women’s health, emotional wellbeing, healthy ageing and sleep support.

Most importantly, it highlights the value of building solutions around well-defined populations and clinically investigated outcomes rather than relying on broad or generic positioning.

Explore the research

Discover the clinical study and executive summary on Affron® and emotional wellbeing during menopause.

Download the study and executive summary

‍